{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:55:56Z","timestamp":1783140956351,"version":"3.54.6"},"reference-count":0,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The basis of fluoroquinolone treatment failure for Mycoplasma genitalium is poorly understood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>To identify mutations associated with failure we sequenced key regions of the M. genitalium parC and gyrA genes for patients undergoing sequential therapy with doxycycline-moxifloxacin (201 patients, including 21 failures) or doxycycline-sitafloxacin (126 patients, including 13 failures).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The parC G248T\/S83I mutation was more common among patients who failed sequential doxycycline-moxifloxacin (present in 76.2% of failures vs 7.8% cures, p&lt;0.001) and doxycycline-sitafloxacin (50% failures vs 16.8% cures, p = 0.014). Doxycycline-sitafloxacin was more efficacious than doxycycline-moxifloxacin against infections carrying the ParC S83I mutation. Infections with a ParC S83I were more likely to fail treatment with a concurrent gyrA mutation (M95I or D99N) (for doxycycline- moxifloxacin group p = 0.067, for doxycycline-sitafloxacin group p = 0.0093), suggesting an additive effect.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study indicates that parC G248T\/S83I mutations contribute to failure of moxifloxacin and sitafloxacin, and will inform the development of quinolone resistance assays needed to ensure optimal selection of antimicrobials for M. genitalium.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiz550","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T07:09:24Z","timestamp":1571382564000},"source":"Crossref","is-referenced-by-count":30,"title":["The parC mutation G248T (S83I), and concurrent gyrA mutations, are associated with moxifloxacin and sitafloxacin treatment failure for Mycoplasma genitalium"],"prefix":"10.1093","author":[{"given":"Gerald L","family":"Murray","sequence":"first","affiliation":[{"name":"The Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, VIC"},{"name":"Centre for Women\u2019s Infectious Diseases, The Royal Women\u2019s Hospital, Parkville, VIC"},{"name":"Molecular Microbiology Research Group, Murdoch Children\u2019s Research Institute, Parkville, VIC"},{"name":"The Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveesha","family":"Bodiyabadu","sequence":"additional","affiliation":[{"name":"The Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, VIC"},{"name":"Centre for Women\u2019s Infectious Diseases, The Royal Women\u2019s Hospital, Parkville, VIC"},{"name":"SpeeDx Pty Ltd, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Danielewski","sequence":"additional","affiliation":[{"name":"Centre for Women\u2019s Infectious Diseases, The Royal Women\u2019s Hospital, Parkville, VIC"},{"name":"Molecular Microbiology Research Group, Murdoch Children\u2019s Research Institute, Parkville, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M","family":"Garland","sequence":"additional","affiliation":[{"name":"The Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, VIC"},{"name":"Centre for Women\u2019s Infectious Diseases, The Royal Women\u2019s Hospital, Parkville, VIC"},{"name":"Molecular Microbiology Research Group, Murdoch Children\u2019s Research Institute, Parkville, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy A","family":"Machalek","sequence":"additional","affiliation":[{"name":"Centre for Women\u2019s Infectious Diseases, The Royal Women\u2019s Hospital, Parkville, VIC"},{"name":"Molecular Microbiology Research Group, Murdoch Children\u2019s Research Institute, Parkville, VIC"},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K","family":"Fairley","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health, Carlton, VIC"},{"name":"Central Clinical School, Monash University, Melbourne, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen S","family":"Jensen","sequence":"additional","affiliation":[{"name":"Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A","family":"Williamson","sequence":"additional","affiliation":[{"name":"The Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lit Y","family":"Tan","sequence":"additional","affiliation":[{"name":"SpeeDx Pty Ltd, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mokany","sequence":"additional","affiliation":[{"name":"SpeeDx Pty Ltd, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Durukan","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health, Carlton, VIC"},{"name":"Central Clinical School, Monash University, Melbourne, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona S","family":"Bradshaw","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre, Alfred Health, Carlton, VIC"},{"name":"Central Clinical School, Monash University, Melbourne, VIC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,22]]},"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz550\/30254391\/jiz550.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz550\/30254391\/jiz550.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T14:49:10Z","timestamp":1571669350000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiz550\/5601895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz550","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"article-number":"jiz550"}}